IFM Investors Pty Ltd Purchases Shares of 4,907 AmerisourceBergen Corp. (ABC)
IFM Investors Pty Ltd purchased a new position in shares of AmerisourceBergen Corp. (NYSE:ABC) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,907 shares of the company’s stock, valued at approximately $406,000.
A number of other institutional investors also recently made changes to their positions in ABC. Parallel Advisors LLC grew its holdings in AmerisourceBergen by 3.2% during the second quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock worth $104,000 after buying an additional 34 shares in the last quarter. Sun Life Financial INC grew its holdings in AmerisourceBergen by 15,000.0% during the second quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock worth $114,000 after buying an additional 1,200 shares in the last quarter. D.A. Davidson & CO. grew its holdings in AmerisourceBergen by 29.0% during the second quarter. D.A. Davidson & CO. now owns 1,668 shares of the company’s stock worth $157,000 after buying an additional 375 shares in the last quarter. Intl Fcstone Inc. bought a new stake in AmerisourceBergen during the second quarter worth $201,000. Finally, Pinnacle Associates Ltd. bought a new stake in AmerisourceBergen during the second quarter worth $203,000. Institutional investors and hedge funds own 67.94% of the company’s stock.
In other news, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction on Wednesday, September 20th. The stock was sold at an average price of $79.47, for a total transaction of $921,852.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Peyton R. Howell sold 17,800 shares of the company’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $89.70, for a total value of $1,596,660.00. The disclosure for this sale can be found here. Insiders have sold a total of 191,207 shares of company stock worth $15,612,018 in the last ninety days. Insiders own 27.40% of the company’s stock.
AmerisourceBergen Corp. (NYSE:ABC) opened at $93.17 on Friday. The company has a debt-to-equity ratio of 1.83, a current ratio of 0.91 and a quick ratio of 0.48. AmerisourceBergen Corp. has a 1 year low of $71.90 and a 1 year high of $97.85. The firm has a market capitalization of $20,318.70, a price-to-earnings ratio of 15.82, a price-to-earnings-growth ratio of 1.61 and a beta of 1.00.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The business had revenue of $39.12 billion for the quarter, compared to analysts’ expectations of $40.10 billion. During the same quarter in the previous year, the firm earned $1.30 earnings per share. The business’s revenue was up 4.2% on a year-over-year basis. equities analysts expect that AmerisourceBergen Corp. will post 6.07 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 4th. Shareholders of record on Monday, November 20th were given a $0.38 dividend. The ex-dividend date was Friday, November 17th. This represents a $1.52 annualized dividend and a yield of 1.63%. This is a boost from AmerisourceBergen’s previous quarterly dividend of $0.37. AmerisourceBergen’s payout ratio is currently 82.16%.
Several equities research analysts recently issued reports on ABC shares. Morgan Stanley downgraded AmerisourceBergen from an “overweight” rating to an “equal weight” rating in a report on Thursday, September 14th. Mizuho set a $92.00 price target on AmerisourceBergen and gave the stock a “hold” rating in a report on Tuesday, October 24th. Zacks Investment Research downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. ValuEngine downgraded AmerisourceBergen from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, Cowen raised AmerisourceBergen from a “market perform” rating to an “outperform” rating in a research report on Tuesday, October 10th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. AmerisourceBergen has an average rating of “Buy” and a consensus price target of $93.20.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with Analyst Ratings Network's FREE daily email newsletter.